1982
DOI: 10.1016/0014-2999(82)90157-1
|View full text |Cite
|
Sign up to set email alerts
|

Vasodilator effects of dopaminomimetics in the perfused rat kidney

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
5
0

Year Published

1984
1984
2005
2005

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 20 publications
(6 citation statements)
references
References 20 publications
1
5
0
Order By: Relevance
“…On the other hand. SKF 38393 in duced a partial agonist activity, which is in agreement with other data reported [Schmidt et al, 1982]. Vasoconstriction, or lack of effects were not observed, as in other prepa rations [Urquilla, 1976;Edvinsson et al, 1978;Goldberg, 1978;Oudart et al.…”
Section: Discussionsupporting
confidence: 82%
“…On the other hand. SKF 38393 in duced a partial agonist activity, which is in agreement with other data reported [Schmidt et al, 1982]. Vasoconstriction, or lack of effects were not observed, as in other prepa rations [Urquilla, 1976;Edvinsson et al, 1978;Goldberg, 1978;Oudart et al.…”
Section: Discussionsupporting
confidence: 82%
“…Therefore, an alteration in renal flow regulation seems also involved. This could be due to an a-receptor-mediated vasoconstriction, second ary to the blockade of beta-2-receptors present in renal vasculature [ 15], or to nonspecific factors involved in the control of renal hemodynamics, such as dopamine or the prostaglandin/kallikrcin system [16][17][18],…”
Section: Discussionmentioning
confidence: 99%
“…While some relaxation was observed with this compound, it was not concentration-dependent , and the concentration required to observe this action was much greater than that produced by SKF 82526. The isolated perfused rat kidney has been used to study the renal vascular DA1 receptors in that dopamine and dopamine receptor agonists are shown to cause dilatation in this preparation by activating the DAI receptors located on renal blood vessels (Woodman, Rechtman & Lang, 1980;Schmidt & Imbs, 1980;Schmidt, Imbs, Giesen & Schwartz, 1982). The failure of LY 171555 to cause renal vasodilation in our study provides the first direct evidence that this compound does not activate the renal vascular DA1 receptors.…”
Section: Discussionmentioning
confidence: 62%